Basel Medical Group Ltd Cash Flow Statement

Cash Flow Statement Jun2024 Jun2025
Operating Activities
Net Income 1.53M-9.12M
Depreciation and Depletion 0.39M0.89M
Asset Writedowns and Impairment 8.41M
Cash from Operations 2.29M-3.28M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) 0.39M0.89M
Change in Working Capital
Change in Receivables -0.31M-5.50M
Change in Inventory 0.02M-0.23M
Change in Account Payables -0.29M-3.27M
Investing Activities
Capital Expenditures 0.01M0.04M
Cash from Investing Activities -0.01M-8.33M
Financing Activities
Other financing activities 1.17M0.03M
Cash from Financing Activities -1.31M12.76M
Additional items
Exchange Rate Effect -0.37M
Change in Cash 0.54M1.15M
Beginning Cash Balance 0.90M1.19M
Free Cash Flow 2.28M-3.32M
Net Cash Flow 0.98M1.15M